Vimarsana
Biggest News Aggregation in the World

Page 8 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio Pharma (NASDAQ:BBIO) Downgraded by Jefferies Financial Group - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Downgraded by Jefferies Financial Group

Jefferies Financial Group cut shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) from a buy rating to a hold rating in a research note published on Monday, Marketbeat reports. They currently have $33.00 price target on the stock, up from their prior price target of $24.00. The analysts noted that the move was a valuation […]

BridgeBio Pharma (NASDAQ:BBIO) Shares Down 3.9% - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Shares Down 3.9%

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report)’s share price dropped 3.9% during mid-day trading on Thursday . The stock traded as low as $17.19 and last traded at $17.31. Approximately 1,190,509 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 2,470,749 shares. The stock had previously closed at […]

Source: wkrb13.com
M28 Capital Management LP Sells 94,300 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Vimarsana News

M28 Capital Management LP Sells 94,300 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)

M28 Capital Management LP lessened its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) by 18.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 419,000 shares of the company’s stock after selling 94,300 shares during the period. BridgeBio Pharma […]

Source: wkrb13.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) CFO Brian C. Stephenson Sells 24,424 Shares - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) CFO Brian C. Stephenson Sells 24,424 Shares

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 24,424 shares of the firm’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $14.01, for a total transaction of $342,180.24. Following the sale, the chief financial officer now owns 36,408 shares in the company, […]

Source: wkrb13.com
Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 51,552 Shares of Stock - Vimarsana News

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 51,552 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 51,552 shares of BridgeBio Pharma stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $14.01, for a total transaction of $722,243.52. Following the completion of the sale, the chief executive officer now directly owns […]